BioSpace News Archive

Agios Pharmaceuticals, Inc. today announced that data from the core period of the pivotal Phase 3 ACTIVATE study of PYRUKYND.

Gracell Biotechnologies Inc. today announced that its abstract providing the follow-up clinical data of GC012F in the treatment of relapsed/refractory multiple myeloma (RRMM) has been selected for oral presentation as part of an Oral Abstract Session at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Alnylam Pharmaceuticals, Inc. announced today that it will report financial results for the first quarter ending March 31, 2022 on Thursday, April 28, 2022, before the U.S. financial markets open.

The PPD clinical research business of Thermo Fisher Scientific and Moderna, whose pioneering mRNA vaccine for COVID has been administered to hundreds of millions globally.

Immunomic Therapeutics, Inc., a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy announced that the company will be presenting at the World Vaccine Congress in Washington, DC being held April 18-21, 2022.

Penumbra, Inc., a global healthcare company focused on innovative therapies, announced that its Indigo Aspiration System with Lightning 7 and Lightning 12 have secured CE Mark and are now commercially available in Europe.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), today announced that it will present at NobleCon18, Noble Capital Markets’ 18th Annual Investor Conference.

Following our Series B, we welcomed new investors to our board: Bpifrance Large Venture, Leonard Green & Partners, and Bristol Myers Squibb. I am delighted to reinforce our organization with our new independent board members to guide our strategy and serve our ambition.

Plus Therapeutics, Inc. announced that the Company will report first quarter 2022 financial results on Thursday, April, 21, 2022, after market close.

Milestone Pharmaceuticals Inc. today announced that the Company will host a virtual Key Opinion Leader (KOL) event on Thursday, April 21, 2022 at 1:00 p.m. ET.